Have a feature idea you'd love to see implemented?
Let us know!
OMER Omeros Corp
Price (delayed)
$7.73
Market cap
$447.95M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$2.31
Enterprise value
$879.87M
Omeros is a commercial-stage biopharmaceutical company committed to discovering, developing and commercializing small-molecule and protein therapeutics for large-market and orphan indications targeting inflammation, complement-mediated diseases, disorders of the central nervous
Highlights
The debt has declined by 7% year-on-year and by 2.5% since the previous quarter
The net income has grown by 3.9% from the previous quarter
Omeros's quick ratio has decreased by 17% from the previous quarter but it has increased by 8% YoY
OMER's equity is down by 24% since the previous quarter
Key stats
What are the main financial stats of OMER
Market
Valuations
Earnings
Shares outstanding
57.95M
Market cap
$447.95M
Enterprise value
$879.87M
Price to earnings (P/E)
N/A
Price to book (P/B)
N/A
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Revenue
$0
EBIT
-$105.96M
EBITDA
-$105.11M
Free cash flow
-$154.91M
Per share
Balance sheet
Liquidity
EPS
-$2.31
Free cash flow per share
-$2.67
Book value per share
-$2.66
Revenue per share
$0
TBVPS
$5.41
Total assets
$313.34M
Total liabilities
$467.51M
Debt
$433.44M
Equity
-$154.17M
Working capital
$109.3M
Debt to equity
-2.81
Current ratio
2.96
Quick ratio
2.33
Net debt/EBITDA
-4.11
Margins
Efficiency
Dividend
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Return on assets
-36.2%
Return on equity
N/A
Return on invested capital
-14.3%
Return on capital employed
-41.1%
Return on sales
N/A
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
OMER stock price
How has the Omeros stock price performed over time
Intraday
28.19%
1 week
11.22%
1 month
88.54%
1 year
360.12%
YTD
136.39%
QTD
94.71%
Financial performance
How have Omeros's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$173.36M
Net income
-$134.53M
Gross margin
N/A
Net margin
N/A
Omeros's operating income has increased by 7% from the previous quarter but it has decreased by 5% YoY
The net income has grown by 3.9% from the previous quarter
Growth
What is Omeros's growth rate over time
Valuation
What is Omeros stock price valuation
P/E
N/A
P/B
N/A
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
OMER's equity is down by 24% since the previous quarter
Efficiency
How efficient is Omeros business performance
The ROA has contracted by 8% from the previous quarter
Dividends
What is OMER's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for OMER.
Financial health
How did Omeros financials performed over time
The total assets is 33% less than the total liabilities
The total assets has contracted by 36% YoY and by 12% from the previous quarter
The current ratio has grown by 24% YoY but it has contracted by 13% from the previous quarter
Omeros's debt to equity has soared by 92% YoY and by 21% from the previous quarter
OMER's equity is down by 24% since the previous quarter
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.